Home › Preeclampsia › NCT07218237
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy Study: MINDBP
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Pregnant patients at gestational age \<= 16 weeks * Live, non-anomalous gestation * Normotensive at enrollment * Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy Exclusion Criteria: * Multiple gestation * Chronic (pregestational hypertension) * Inability of unwillingness to provide informed consent * Active suicidality or psychosis * Ongoing mind-body practice (e.g., yoga, meditation, mindfulness \>= once per week)
About the study
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.
What is being tested
- Mindfulness training (behavioral)
- Garmin Vivoactive 4 watch (behavioral)
Sponsor: Medical College of Wisconsin · Participants: 90 · Started: Apr 1, 2026
Contact the study team
- Anna Palatnik, MD · Phone: 14148056627
- Alyssa Hernandez, DO · Phone: 4149552781
Official record on ClinicalTrials.gov — NCT07218237
Locations in the U.S.
| Rhode Island | Brown University, Providence |
| Wisconsin | Medical College of Wisconsin, Milwaukee |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.